Syngene

BSE: 539268 | NSE: SYNGENE
Syngene (CIN: L85110KA1993PLC014937) operates in the Pharmaceuticals industry and has been listed in the stock market since 11th Aug 2015. It currents trades on NSE with symbol SYNGENE and on BSE with scrip code 539268.
The registered office of the company is Biocon Park SEZ, Jigani Link Road, Bommasandra IV Phase,Bengaluru,Karnataka,560099.

The management team of Syngene is led by Mrs. KIRAN MAZUMDAR SHAW who is the Executive Director-Chairperson. Other members of the management team consist of Mr. JOHN SHAW (Designation:Non-Executive - Non Independent Director), Mr. JONATHAN HUNT (Designation:Executive Director), Mrs. CATHERINE ROSENBERG (Designation:Non-Executive - Non Independent Director), Mr. RUSSELL WALLS (Designation:Non-Executive - Independent Director), Mr. PAUL BLACKBURN (Designation:Non-Executive - Independent Director), Mr. SURESH TALWAR (Designation:Non-Executive - Independent Director), Mr. VIJAY KUCHROO (Designation:Non-Executive - Independent Director), Ms. VINITA BALI (Designation:Non-Executive - Independent Director), Mr. BALA S MANIAN (Designation:Non-Executive - Independent Director), Mayank Verma (Designation:Company Secretary & Compliance Officer), .

The price and other financial information of Syngene is as below -

BSE 581.3 0.9 (0.16%)

BSE

581.3 0.9 (0.16%)
Volume: 1,460.00
M. Cap: 11,626.00
P/E: 36.88
Prev. Close: 580.40
Day
52 Wk

NSE

584.45 -1.05 (-0.18%)
Volume: 41,917.00
M. Cap: 11,626.00
P/E: 36.88
Prev. Close: 585.50
Day
52 Wk

Stock Price Chart

Shareholding Pattern

Category No. of shares Percent(%)
Promoters 14,21,01,495 71.05
Foreign Institutions 3,30,29,466 16.51
General Public 95,95,627 4.80
NBFC and Mutual Funds 95,78,533 4.79
Others 20,67,647 1.03
GDR 20,38,001 1.02
Financial Institutions 15,85,731 0.79
ForeignPromoter 3,500 0.00
Total 20,00,00,000 99.99

NSE Trade Data

Trade Snapshot
VWAP 581.46
Face Value 10.00
Traded Volume (shares) 41,917.00
Traded Value (lacs) 243.73
Free Float Market Cap (Crs) 3,251.64
52 week high 700.00
52 week low 500.10
Lower Price Band 468.40
Upper Price Band 702.60
Security-wise Delivery Position
Quantity Traded 41,917.00
Deliverable Quantity (gross across client level) 13,835.00
% of Deliverable Quantity to Traded Quantity 33.01 %
Value at Risk (VaR in %)
Security VaR 3.63
Index VaR -
VAR Margin 7.50
Extreme Loss Rate 5.00
Adhoc Margin -
Applicable Margin Rate 12.50

Financial Data

Consolidated
Figures in crore 2018
Net Sales 1,423.10
Operating Profit 526.60
Other Income 135.70
Interest 22.70
Depreciation 131.40
Profit Before Tax 372.50
Tax 67.10
Profit After Tax 305.40
Share Capital 200.00
Reserves 1,520.40
Net Worth 1,720.40
Loans 886.90
Gross Block 1,660.70
Investments 157.70
Cash 967.40
Debtors 266.80
Net Working Capital 1,263.80
Operating Profit Margin (%) 37.00
Net Profit Margin (%) 21.46
Earning Per Share (Rs) 15.06
Dividend (%) 10.00
Dividend Payout 20.00
Standalone
Figures in crore 2018 2017 2016
Net Sales 1,423.10 1,200.90 1,107.00
Operating Profit 526.20 478.30 386.70
Other Income 135.70 93.60 6.30
Interest 22.70 17.50 8.40
Depreciation 131.40 114.30 97.30
Profit Before Tax 372.10 346.50 281.00
Tax 67.00 59.20 40.20
Profit After Tax 305.10 287.30 240.80
Share Capital 200.00 200.00 200.00
Reserves 1,520.10 1,213.10 824.70
Net Worth 1,720.10 1,413.10 1,024.70
Loans 886.90 878.00 962.60
Gross Block 1,660.70 1,331.90 1,111.40
Investments 158.00 540.40 276.60
Cash 966.50 527.30 719.90
Debtors 266.80 198.70 185.20
Net Working Capital 1,263.20 765.40 893.70
Operating Profit Margin (%) 36.98 39.83 34.93
Net Profit Margin (%) 21.44 23.92 21.75
Earning Per Share (Rs) 15.05 14.37 11.84
Dividend (%) 10.00 10.00 10.00
Dividend Payout 20.00 0.00 20.00
Dividend Declared (₹)
The company has declared dividend 3 times between 17 Mar 2016 and 17 Jul 2018, totaling Rs. 3.00 so far. The most dividend was declared on 17 Jul 2018 for Rs. 1.

Financial Data Graph

The peers of Syngene are AUROPHARMA, IOLCP and AJANTPHARM.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*

Popular Comments

No comment posted for this article.